Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088537/0/en/ORYZON-to-Provide-Corporate-Progress-Updates-at-Several-Events-in-May-June.html
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079076/0/en/ORYZON-Reports-Financial-Results-and-Corporate-Update-for-Quarter-Ended-March-31-2025.html
08 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/08/3077169/0/en/ORYZON-Awarded-13-26-Million-Through-the-First-Important-Project-of-Common-European-Interest-IPCEI-in-the-Health-Sector-Med4Cure-Project.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067368/0/en/ORYZON-Raises-30-Million-in-Capital-Increase.html
21 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/21/3064596/0/en/ORYZON-Continues-to-Strengthen-its-Patent-Portfolio-for-Vafidemstat.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3061672/0/en/ORYZON-Announces-First-Patient-Dosed-in-NCI-Sponsored-Phase-I-II-Clinical-Trial-of-Iadademstat-Plus-Immune-Checkpoint-Inhibitors-in-1L-Extensive-Stage-Small-Cell-Lung-Cancer.html
ABOUT THIS PAGE